Skip to content

Clinical trials

Completed Phase 1 Neuralgia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 1 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20071
20082
20101
20115
20122
20132
20143
20153
20164
20172
20181
20192
20203
20221
20232
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen3
GL Pharm Tech Corporation2
GlaxoSmithKline2
IlDong Pharmaceutical Co Ltd2
Relmada Therapeutics, Inc.2
Stanford University2
University Children's Hospital, Zurich2
University Hospital, Clermont-Ferrand2
4E Therapeutics1
Afasci Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia40
Chronic Pain8
Pain8
Neuralgia, Postherpetic3
Diabetic Neuropathies2
Headache2
Hyperalgesia2
Movement Disorders2
Nociceptive Pain2
Osteoarthritis2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.